Clinical Trial Update: Letrozole in Preventing Breast Cancer in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate letrozole for the prevention of breast cancer in postmenopausal women, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-29